Literature DB >> 8392778

Evaluation of MRI score in the differentiation between glioblastoma multiforme and metastatic adenocarcinoma of the brain.

S Asari1, T Makabe, S Katayama, T Itoh, S Tsuchida, K Kunishio, T Ohmoto.   

Abstract

The authors statistically analyzed the MR configurations of 14 glioblastoma multiformes (GBMs) and 15 metastatic adenocarcinomas (MACs) of the brain in order to distinguish these two histological types on MR images. MR configurations were classified and scored upon the 9 criteria of heterogeneity, cyst or necrosis, haemorrhage, crossing of the midline by the tumour, oedema or mass effect, border definition, flow void sign, degree and heterogeneity after contrast enhancement. The mean value of GBMs was 1.47 +/- 0.22, and that of MACs was 0.91 +/- 0.37 (P < 0.001). GBMs had significantly higher values in five out of the nine criteria: border definition, heterogeneity, crossing of the midline of the tumour, flow void sign, and degree of the contrast enhancement (P < 0.001-0.05). Border definition was the best criterion for distinguishing two histological types. Six cases of MACs displayed hypo-intense lesions on T2 weighted images in contrast to GBMs which showed hyperintense lesions in all cases. In 4 out of the 6 MACs which were shown as hyperintensities on T2 weighted images, a hypo-intense peritumoural rim was noticed between the tumour parenchyma and the surrounding oedema. These data strongly suggest that GBMs and MACs can be distinguished on MR image by using MRI score.

Entities:  

Mesh:

Year:  1993        PMID: 8392778     DOI: 10.1007/bf01446987

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  12 in total

1.  Tumours of the central nervous system. Proton magnetic resonance relaxation times T1 and T2 and histopathologic correlates.

Authors:  E Englund; A Brun; E M Larsson; Z Györffy-Wagner; B Persson
Journal:  Acta Radiol Diagn (Stockh)       Date:  1986 Nov-Dec

2.  MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values.

Authors:  M Komiyama; H Yagura; M Baba; T Yasui; A Hakuba; S Nishimura; Y Inoue
Journal:  AJNR Am J Neuroradiol       Date:  1987 Jan-Feb       Impact factor: 3.825

3.  MR recognition of supratentorial tumors.

Authors:  B C Lee; J B Kneeland; P T Cahill; M D Deck
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

4.  Human cerebral gliomas: correlation of postmortem MR imaging and neuropathologic findings.

Authors:  P C Johnson; S J Hunt; B P Drayer
Journal:  Radiology       Date:  1989-01       Impact factor: 11.105

5.  [MR findings of metastatic brain tumors].

Authors:  K Tsuchiya; K Makita; T Irie; Y Wada; E Takenaka
Journal:  Rinsho Hoshasen       Date:  1989-10

6.  Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors.

Authors:  M Just; M Thelen
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

7.  Preliminary clinical results of proton (1H) imaging of cranial neoplasms: in vivo measurements of T1 and mobile proton density.

Authors:  T J Brady; F S Buonanno; I L Pykett; P F New; K R Davis; G M Pohost; J P Kistler
Journal:  AJNR Am J Neuroradiol       Date:  1983 May-Jun       Impact factor: 3.825

8.  Magnetic resonance imaging of brain tumors: measurement of T1. Work in progress.

Authors:  T Araki; T Inouye; H Suzuki; T Machida; M Iio
Journal:  Radiology       Date:  1984-01       Impact factor: 11.105

9.  Results of nuclear magnetic resonance with cerebral glioma. Comparison with computed tomography.

Authors:  D W Laster; M R Ball; D M Moody; R L Witcofski; D L Kelly
Journal:  Surg Neurol       Date:  1984-08

10.  Contrast-enhanced MR imaging of malignant brain tumors.

Authors:  M Graif; G M Bydder; R E Steiner; P Niendorf; D G Thomas; I R Young
Journal:  AJNR Am J Neuroradiol       Date:  1985 Nov-Dec       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.